F-group (family)
5073.1.1.4 Cation_ATPase_C,Cation_ATPase_N
Ligands and drugs
454
Member domains
246
with ligand contacts (≤ 4 Å)
54.2% of members
223
with DrugDomain annotations
49.1% of members
141
with a DrugBank compound
31.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5073.1.1.4 belongs to X-group 5073 Calcium ATPase transmembrane domain-related, which binds 9.1 ligand superclasses per 20 proteins, broader than 82% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04540 | CLR | Cholesterol | 101 |
| DB03690 | PCW | (Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide | 76 |
| DB01092 | OBN | Ouabain | 15 |
| DB07604 | CZA | (6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE | 12 |
| DB00390 | DGX | Digoxin | 5 |
| DB18573 | 17F | 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine | 4 |
| DB01396 | F9R | Digitoxin | 3 |
| DB04638 | BHQ | 2,5-di-tert-butylhydroquinone | 2 |
| DB12350 | E4R | Rostafuroxin | 2 |
| DB00228 | — | — | 1 |
| DB00511 | — | — | 1 |
| DB00753 | — | Isoflurane | 1 |
| DB00774 | — | Hydroflumethiazide | 1 |
| DB00903 | — | Etacrynic acid | 1 |
| DB01021 | — | — | 1 |
| DB01028 | — | — | 1 |
| DB01078 | — | — | 1 |
| DB01119 | — | Diazoxide | 1 |
| DB01158 | — | — | 1 |
| DB01188 | — | Ciclopirox | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLR | CHOLESTEROL | 111 |
| PCW | 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 88 |
| NAmetal | SODIUM ION | 67 |
| MGmetal | MAGNESIUM ION | 57 |
| Kmetal | POTASSIUM ION | 45 |
| TG1 | OCTANOIC ACID [3S-[3ALPHA, 3ABETA, 4ALPHA, 6BETA, 6ABETA, 7BETA, 8ALPHA(Z),9BALPHA]]-6-(ACETYLOXY)-2,3,-3A,4,5,6,6A,7,8,9B-DECAHYDRO-3,3A-DIHYDROXY-3,6,9-TRIMETHYL-8-[(2-METHYL-1-OXO-2-BUTENYL)OXY]-2-OXO-4-(1-OXOBUTOXY)-AZULENO[4,5-B]FURAN-7-YL ESTER | 38 |
| CAmetal | CALCIUM ION | 37 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 20 |
| RBmetal | RUBIDIUM ION | 20 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 17 |
| TLmetal | THALLIUM (I) ION | 14 |
| OBN | OUABAIN | 13 |
| CZA | (6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE | 12 |
| CE1 | O-DODECANYL OCTAETHYLENE GLYCOL | 10 |
| A1MA6 | palytoxin | 9 |
| MNmetal | MANGANESE (II) ION | 7 |
| 7Q2 | (3E,5S,8R,9S,10R,13S,14S)-3-(2-azanylethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione | 6 |
| BUF | bufalin | 6 |
| DMU | DECYL-BETA-D-MALTOPYRANOSIDE | 5 |
| 17F | O-[(S)-({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine | 4 |